Vaxcyte, Inc. — Director's Dealing 2024

Feb 2, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2024-01-31

Reporting Person: Lukatch Heath (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-01-31	Common Stock	M	5000	$16	Acquired	10625	Direct
2024-01-31	Common Stock	S	5000	$71.50	Disposed	5625	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-01-31	Stock Option (right to buy)	$16	M	5000	Disposed	2030-06-10	Common Stock (5000)	Direct

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2023.

F2: Fully vested and exercisable.